Sébastien Hess

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui et al. · The Lancet · 2020 · 130 citations

Medicine, Cardiology, Pharmacology +14

Impact of Malignancies in the Early and Late Time Course of Takotsubo Cardiomyopathy

Mélanie Girardey, Laurence Jesel, Umberto Campia et al. · Circulation Journal · 2016 · 48 citations · Full text

Medicine, Cardiology, Oncology +6

COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway

Ali Mroueh, Walaa Fakih, Adrien Carmona et al. · Journal of Thrombosis and Haemostasis · 2023 · 39 citations · Full text

Veterinary Medicine, Cell Biology, Pathology +14

The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: Roles of white blood cell count and body weight

Soraya El Ghannudi, Sébastien Hess, Antje Reydel et al. · Thrombosis and Haemostasis · 2012 · 31 citations

Medicine, Cardiology, Pharmacology +17

Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic

Kensuke Matsushita, Sébastien Hess, Benjamin Marchandot et al. · Journal of Thrombosis and Thrombolysis · 2020 · 29 citations · Full text

Medicine, Cardiology, Internal Medicine +16